Evidence map›Paper›PMID 39882241›Full record

ReviewFrontiers in immunology2024

Elusive modes of Foxp3 activity in versatile regulatory T cells.

Minghong He, Yongqiang Feng

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Minghong HeDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, United States.
Yongqiang FengDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, United States.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
Robust immune tolerance conferred by Foxp3 transcriptional regulationR01AI153138 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI FENG, YONGQIANG · 2021 to 2025
$2.2M
Identify novel modulators of regulatory T cell function from the dynamic cis-proteomesR21AI163942 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI FENG, YONGQIANG · 2021 to 2022
$494k
NCI NIH HHS P30 CA021765NIAID NIH HHS R01 AI153138NIAID NIH HHS R21 AI163942
6 · The paper itself

Abstract

Foxp3-expressing CD4 regulatory T (Treg) cells play a crucial role in suppressing autoimmunity, tolerating food antigens and commensal microbiota, and maintaining tissue integrity. These multifaceted functions are guided by environmental cues through interconnected signaling pathways. Traditionally, Treg fate and function were believed to be statically determined by the forkhead box protein Foxp3 that directly binds to DNA. However, this model has not been rigorously tested in physiological and pathological conditions where Treg cells adapt their function in response to environmental cues, raising questions about the contribution of Foxp3-dependent gene regulation to their versatility. Recent research indicates that Foxp3 primarily functions as a transcriptional cofactor, whose chromatin interaction is influenced by other DNA-binding proteins that respond to cell activation, stimulation, or differentiation. This new perspective offers an opportunity to reevaluate Foxp3's activity modes in diverse biological contexts. By exploring this paradigm, we aim to unravel the fundamental principles of Treg cell biology.

Indexed as

Forkhead Transcription FactorsT-Lymphocytes, RegulatoryAnimalsCell DifferentiationGene Expression RegulationHumansLymphocyte ActivationSignal TransductionForkhead Transcription FactorsFOXP3 protein, humanchromatinDNA bindingFoxp3regulatory T cellstranscriptional cofactortranscription factor

Identifiers

PMID39882241
PMCPMC11774722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.